Executive Leadership Group
Rodney J.Y. Ho, PhD
Executive Director of WE-REACH
Dr. Rodney Ho brings over 30 years’ experience as a researcher on cancer and HIV, a founder of multiple successful startups, and a fundraiser of over $150MM in private funds to the leadership of WE-REACH. In addition to WE-REACH, Dr. Ho is the PI of the TLC-ART Program and a professor of pharmaceutics at the University of Washington.
Terri Butler, PhD
Associate Director of Technology Outreach & Partnerships
Dr. Butler has co-invented more than a dozen patents, managed nonprofits, and has held director-level positions at Soluxra, ITHS, and the Buerk Center for Entrepreneurship–where she ran the Holloman Health Innovation Challenge. In addition to organizing outreach and communications, Dr. Butler runs the WE-REACH Biomedical Innovation Bootcamp.
Matthew Hartman, PhD
WE-REACH Acting Associate Director of Technology Development
Dr. Hartman is the Acting Associate Director of Technology Development for WE-REACH. He has organized, managed, and coordinated the center since its founding. He runs grant application cycles, sets up funded projects, and interfaces with funders and supporters. He also works with the TLC-ART Program.
Fiona Wills, PhD
Assistant Vice President, Innovation Development at CoMotion
Dr. Wills serves as assistant VP of CoMotion (the UW Tech transfer office). She brings her expertise in IP, project funding, and technology management to the governance of WE-REACH.
Ryan Buckmaster, MS
Ryan serves at Associate Director, Innovation Investments at CoMotion (the UW Tech transfer office). He has worked with CoMotion since 2010 and has expertise in innovations in microelectronics, optics, materials, and medical devices. He has done graduate work at Tohoku University on the development of novel nanostructure fabrication methods, and at the University of Washington on optical spectroscopy based real-time single cell analysis systems.
Andy Stergachis, PhD
Associate Dean of the University of Washington School of Pharmacy
Dr. Stergachis is the associate dean of the UW School of Pharmacy, a professor of pharmacy, and a global health & adjunct professor of epidemiology and health services. He is an author of over 160 peer-reviewed publications and served as Editor-in-Chief of the Journal of the American Pharmacists Association.
Tong Sun, MS, MBA
Executive Director of the Institute of Translational Health Sciences
Mr. Sun serves as the Executive Director of ITHS. Prior to his appointment at ITHS, he served as Vice President of Central Operations for Houston Methodist Research Institute (HMRI), where he was responsible for the development, oversight, and operational implementation of the HMRI Translational Research Initiative (TRI).
Teddy Johnson, PE, MBA
ITHS Director of Technology Development
Teddy joined the healthcare community over 25 years ago and has served start-up and Fortune 500 companies in research, design, clinical, marketing, and sales leadership roles; developing imaging, interventional, surgical, and pharmaceutical products. Along the way, Teddy has celebrated 2 IPO’s and 3 acquisitions, while earning numerous patents and commercializing dozens of new products worldwide. As a way of fostering innovation, Teddy is a UW STEM lecturer and advises startup CEOs in Seattle and the Silicon Valley on clinical and commercialization strategies.
Lance Stewart, PhD, MBA
Chief Strategy and Operations Officer of the Institute for Protein Design
Dr. Stewart is the Chief Strategy and Operations Officer of IPD. He brings more than 23 years of experience in protein and drug discovery research, life sciences partnering and entrepreneurial start-up activities to WE-REACH.
Aaron Haley, MA
WE-REACH Program Coordinator
David serves as the Program Coordinator for the WE-REACH team.